You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Burkitt Lymphoma

Showing 1 - 25 of 4,654
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Burkitt Lymphoma, High-grade B-cell Lymphoma, T-cell/Histocyte-rich Large B-cell Lymphoma Trial run by the NCI (Rituximab,

Recruiting
  • Burkitt Lymphoma
  • +4 more
  • Rituximab
  • +6 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 15, 2022

Burkitt's Lymphoma, Burkitt's Leukemia, Mediastinal Tumors Trial in Frankfurt (Adriamycin, Cyclophosphamide, Cytarabine)

Completed
  • Burkitt's Lymphoma
  • +4 more
  • Frankfurt, Germany
    University Hospital, Medical Dept. II
Aug 17, 2022

Burkitt Lymphoma, Retinoblastoma, Diffuse Large B-cell Lymphoma Trial in Mwanza (mNavigator)

Active, not recruiting
  • Burkitt Lymphoma
  • +2 more
  • mNavigator
  • Mwanza, Lake Zone, Tanzania
    Bugando Medical Centre
Mar 7, 2022

Relapsed/Refractory Waldenstrom Macroglobulinemia, Relapsed/Refractory Richter Transformation, Relapsed/Refractory Burkitt

Not yet recruiting
  • Relapsed/Refractory Waldenstrom Macroglobulinemia
  • +3 more
  • Brexucabtagene Autoleucel
  • +2 more
  • (no location specified)
Sep 8, 2022

Lymphoma, Non-Hodgkin Lymphoma, DLBCL Trial run by the National Cancer Institute (NCI) (Venetoclax, Ibrutinib, Prednisone)

Recruiting
  • Lymphoma
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 20, 2022

Diffuse Large Cell Lymphoma, Non-Hodgkin Lymphoma, Burkitt Lymphoma Trial run by the National Cancer Institute (NCI)

Not yet recruiting
  • Diffuse Large Cell Lymphoma
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 17, 2022

Lymphoma, Non-Hodgkin Lymphoma, DLBCL Trial run by the NCI (obinutuzumab, prednisone, Revlimid)

Recruiting
  • Lymphoma
  • +3 more
  • obinutuzumab
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 6, 2022

DLBCL (DLBCL), Primary Mediastinal Large B-cell Lymphoma, Burkitt Lymphoma Trial run by the National Cancer Institute (NCI)

Active, not recruiting
  • Diffuse Large B-Cell Lymphoma (DLBCL)
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 24, 2022

Children With Burkitt's Lymphoma

Recruiting
  • Burkitt Lymphoma
  • OBSERVATIONAL
  • Ouagadougou, Burkina Faso
  • +6 more
Oct 26, 2021

GastroIntestinal Cancer in Children and Adolescents

Active, not recruiting
  • Gastrointestinal Cancer
  • +6 more
    • Leiden, South-Holland, Netherlands
    • +1 more
    Jan 11, 2023

    Burkitt Lymphoma, KSHV-associated Multicentric Castleman Disease, DLBCL Trial in Kampala (Rituximab and Hyaluronidase Human,

    Recruiting
    • Burkitt Lymphoma
    • +2 more
    • Rituximab and Hyaluronidase Human
    • +8 more
    • Kampala, Uganda
      UCI-Fred Hutch Cancer Centre
    Mar 9, 2022

    Lymphoma, Leukemia Trial in United States (CPI-613)

    Recruiting
    • Lymphoma
    • Leukemia
    • Duarte, California
    • +9 more
    Dec 28, 2021

    Refractory Non-Hodgkin Lymphoma, Burkitt Lymphoma, Mantle Cell Lymphoma Trial in San Francisco (Fludarabine, Cyclophosphamide,

    Recruiting
    • Refractory Non-Hodgkin Lymphoma
    • +8 more
    • San Francisco, California
      University of California, San Francisco
    May 2, 2022

    AIDS-Related Burkitt Lymphoma, AIDS-Related Diffuse Large B-cell Lymphoma, AIDS-Related Plasmablastic Lymphoma Trial run by the

    Active, not recruiting
    • AIDS-Related Burkitt Lymphoma
    • +5 more
    • Bethesda, Maryland
      NCI Lymphoid Malignancies Branch
    Jul 31, 2022

    Acute Myeloid Leukemia (AML), Acute Lymphocytic Leukemia in Relapse, Burkitt's Lymphoma Stage III Trial in Hartford, Calgary,

    Recruiting
    • Acute Myeloid Leukemia (AML)
    • +4 more
    • Individualized Yoga Intervention Group
    • iPad Activity Control Group
    • Hartford, Connecticut
    • +2 more
    Sep 16, 2021

    B-cell Lymphoma, Burkitt Lymphoma, Diffuse Large B Cell Lymphoma Trial in Valhalla (Polatuzumab vedotin)

    Recruiting
    • B-cell Lymphoma
    • +8 more
    • Polatuzumab vedotin
    • Valhalla, New York
      New York Medical Center
    Oct 29, 2021

    Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Lymphoblastic Lymphoma Trial in Valhalla, Charlotte (Clofarabine,

    Active, not recruiting
    • Acute Lymphoblastic Leukemia
    • +4 more
    • Valhalla, New York
    • +1 more
    Oct 29, 2021

    Acute Leukemia, Acute Myeloid Leukemia, MDS Trial in Philadelphia (CliniMACS Cell Processing System for TCRaß + T Cell and

    Recruiting
    • Acute Leukemia
    • +7 more
    • CliniMACS Cell Processing System for TCRαβ + T Cell and CD45RA Depleted Peripheral Stem Cell Addback
    • Philadelphia, Pennsylvania
      Children's Hospital of Philadelphia
    Mar 21, 2022

    High-grade B-cell Lymphoma, Burkitt Lymphoma, Lymphoma, B-Cell Trial in Busan, Seoul (Sepantronium Bromide)

    Not yet recruiting
    • High-grade B-cell Lymphoma
    • +8 more
    • Sepantronium Bromide
    • Busan, Korea, Republic of
    • +5 more
    Feb 27, 2022

    Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Triple Negative Breast Cancer Trial in United States

    Recruiting
    • Non Small Cell Lung Cancer
    • +11 more
    • Denver, Colorado
    • +3 more
    Jan 10, 2023

    Mature B-Cell Tumor, Non Hodgkin Lymphoma, DLBCL Trial (SGR-1505)

    Not yet recruiting
    • Mature B-Cell Neoplasm
    • +25 more
    • (no location specified)
    Sep 14, 2022

    Mature B-Cell Leukemia Burkitt Type, Burkitt Lymphoma (BL), Unclassifiable Lymphoma Between DCBL and BL Trial in Spain

    Recruiting
    • Mature B-Cell Leukemia Burkitt Type
    • +2 more
    • Badalona, Barcelona, Spain
    • +28 more
    Sep 17, 2021

    Diffuse Large Cell Lymphoma, Burkitt's Lymphoma, High Grade B-cell Lymphoma Trial in United States (Rituximab, IT Cytarabine)

    Completed
    • Diffuse Large Cell Lymphoma
    • +2 more
    • Buffalo, New York
    • +4 more
    Oct 29, 2021

    Diffuse Large B Cell Lymphoma, Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia Trial in Wuhan (BTK inhibitor+ Fludarabine +

    Recruiting
    • Diffuse Large B Cell Lymphoma
    • +4 more
    • BTK inhibitor+ Fludarabine + Cyclophosphamide + CAR-T-CD19 Cells
    • Fludarabine + Cyclophosphamide + CAR-T-CD19 Cells
    • Wuhan, Hubei, China
      Union Hospital, Huazhong University of Science and Technology
    Oct 13, 2021

    B-cell Lymphoma, Burkitt Lymphoma Trial in Milwaukee (Etoposide, Doxorubicin, Cyclophosphamide)

    Not yet recruiting
    • B-cell Lymphoma
    • Burkitt Lymphoma
    • Milwaukee, Wisconsin
      Froedtert Hospital & the Medical College of Wisconsin
    Jun 11, 2022